Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations

Published:2023-07 Issue: Volume:174 Page:148-156
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Rimel Bobbie J.,Crane Erin K.,Hou June,Nakayama John,MacDonald Jennifer,Lutz Kathleen,Makker Vicky,O'Cearbhaill Roisin E.

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference43 articles.

1. Properties of FDA-approved small molecule protein kinase inhibitors: a 2023 update;Roskoski;Pharmacol. Res.,2022

2. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial;van der Graaf;Lancet.,2012

3. Lenvatinib plus pembrolizumab for advanced endometrial cancer;Makker;N. Engl. J. Med.,2022

4. Lenvima (Lenvatinib) [Prescribing Information];Eisai Inc,2021

5. Clinicopathologic significance of mismatch repair defects in endometrial cancer: an NRG oncology/gynecologic oncology group study;McMeekin;J. Clin. Oncol.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future;Expert Opinion on Drug Metabolism & Toxicology;2024-09-09

2. The Hippo pathway in endometrial cancer: a potential therapeutic target?;Frontiers in Oncology;2023-10-20

3. Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report;Oncology Letters;2023-08-31

4. Toxicity in combined therapies for tumours treatments: a lesson from BAG3 in the TME?;Frontiers in Immunology;2023-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3